FIELD: medicine; pharmacology.
SUBSTANCE: preparation for application in photon capture therapy of malignant solid neoplasms represents pharmaceutical substance, which composition of which includes diethylenetriaminopentaacetic acid in form of its disodium salt, characterised by the fact that as pharmaceutical composition used is complex of bismuth with diethylenetriaminopentaacetic acid (H5dtpa) in form of its disodium salt BiNa2dtpa with general formula and in the following weight ratio: BiNa2dtpa (BiNa2C14H18O10N3) 305.0-330.0 mg; diethylenetriaminopentaacetic acid (H5dtpa) 0.1 mg, or 0.2 mg, or 0.3 mg.
EFFECT: improvement of properties.
2 cl, 2 ex, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
GADOPENTETATE-MODIFIED BETA-CYCLODEXTRIN DERIVATIVES | 2013 |
|
RU2541090C1 |
MEDICINAL CONTRAST COMPOSITION | 2016 |
|
RU2639390C2 |
METHOD FOR APPLYING PHOTON-CAPTURING TUMOR THERAPY | 2004 |
|
RU2270045C1 |
CONTRAST GADOLINIUM COMPLEX COMPOSITION FOR MEDICAL DIAGNOSTICS | 2009 |
|
RU2396983C1 |
MAGNETIC RESONANCE AND RADIOPAQUE COMPOSITION | 2006 |
|
RU2308290C1 |
MEGNETIC-RESONANCE OPAQUE COMPOSITION | 1998 |
|
RU2150961C1 |
METHOD OF PROTON THERAPY FOR SOLID EHRLICH CARCINOMA | 2023 |
|
RU2808984C1 |
METHOD FOR PHOTON CAPTURE THERAPY OF TUMOURS | 2013 |
|
RU2533267C1 |
METHOD FOR DETERMINING NEUTRON- CAPTURING ONCOLOGICAL PREPARATIONS EFFECTIVENESS IN EXPERIMENTS | 1998 |
|
RU2144669C1 |
PHARMACOLOGICAL COMBINATION OF POLYCATIONIC CARRIER PEG-PEI-TAT WITH INCLUDED IN IT PLASMID CARRYING THERAPEUTIC GENES HSVtk AND GM-CSF FOR GENE THERAPY OF TUMOROUS DISEASES | 2013 |
|
RU2575077C2 |
Authors
Dates
2017-02-21—Published
2015-12-01—Filed